Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity
2025 · JHEP Reports · 2 citations
https://doi.org/10.1016/j.jhepr.2025.101513
M
Matthias Thaler
LMU Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
12
Citations
2
h-index
0
i10-index
Matthias Thaler is an academic researcher from LMU Klinikum. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 2, co-authored 10 publications.
Papers by this author
worksImmune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer
2024 · Journal of Vascular and Interventional Radiology · 1 citations
https://doi.org/10.1016/j.jvir.2024.07.010
Cardiac disease in patients with vasculitis
2025 · Clinical Research in Cardiology · 0 citations
https://doi.org/10.1007/s00392-025-02728-y
Stimulator of Interferon Genes Ablation in T Cells Is Required for the Efficacy of Stimulator of Interferon Genes Agonists in Chimeric Antigen Receptor-T Cell Immunotherapy of Pancreatic Cancer
2026 · Gastroenterology · 0 citations
https://doi.org/10.1053/j.gastro.2026.01.031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat